foxo4-dri apoptosis Development of a novel senolytic by precise disruption of FOXO4-p53 complex Immunofluorescence reveals the effect of
Immunofluorescence reveals the effect of FOXO4 D Retro Inverso on p53 Download Scientific Diagram Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI Results: What to Expect (2026) FOXO4 DRI For Lab Research Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




